Dina Titus (D-NV)
Evidence-Based Drug Policy Act of 2025
A Democratic bill with 2 Democratic cosponsors · See all 2 cosponsors
Last activity — Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
In committee
Introduced and handed to a committee in the chamber it started in.
The committee holds it, and most bills are never heard from again. A hearing or a committee vote would be news; silence is the usual outcome, and it kills the bill without anyone voting against it.
Its path through Congress
- Introduced
- In Committee
What this bill would do
This bill is titled the ``Evidence-Based Drug Policy Act of 2025''. The primary purpose of the legislation is to repeal section 704(b)(12) of the Office of National Drug Control Policy Reauthorization Act of 1998. This specific section is found at 21 U.S.C. 1703(b)(12). The bill was introduced by Ms. Titus and Ms. Omar.
Yes
- Scored +1
Would people with disabilities be better off under this?
A shift to evidence-based drug policy may impact access to various forms of medical treatment and support.
- Scored +1
Does this do more about addiction and overdose deaths?
The bill's title suggests a shift toward evidence-based drug policies which may influence the national response to addiction.
The opposite
No question was scored the opposite.
Who it would affect, and how
Potential Positive Impacts for People
- The provided text does not contain information explaining the specific contents of section 704(b)(12) or the potential benefits of its repeal.
Potential Negative Impacts for People
- The provided text does not contain information explaining the specific contents of section 704(b)(12) or the potential burdens caused by its repeal.
Groups and Interests Ranking
Every group the model scored this bill for, from -10 to +10. Tap or hover a score for the reason it gave.
- Demographic And Interest Groups
- Would people with disabilities be better off under this? — A shift to evidence-based drug policy may impact access to various forms of medical treatment and support.
- Healthcare
- Does this do more about addiction and overdose deaths? — The bill's title suggests a shift toward evidence-based drug policies which may influence the national response to addiction.
- 5/20/2026
- 1 Cosponsor added.
- 4/29/2025
- Referred to the Committee on Oversight and Government Reform, and in addition to the Committees on Energy and Commerce, and the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
- 1 Cosponsor added.
- Introduced in House
Eleanor NortonDemocrat · District of Columbia
Ilhan OmarDemocrat · Minnesota